MedTrace Logo

Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients

NCT02434133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2018-11-27

No results posted yet for this study

Summary

The investigators proposed study is the first of its kind. The investigators will measure measles, mumps, rubella, tetanus, diphtheria and pertussis antibodies in patients on the current IBD treatment modalities and compare the vaccine antibody concentrations and correlate them with time since immunization.

Conditions

  • Inflammatory Bowel Disease (IBD)

Interventions

PROCEDURE

Blood Draw/Data Collection

Participation will involve an extra 8ml tube of blood and a review of their medical records for medications and immunization history.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434133 on ClinicalTrials.gov